{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:30:41Z","timestamp":1788881441976,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,15]]},"DOI":"10.1093\/cid\/ciu185","type":"journal-article","created":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T03:21:31Z","timestamp":1395285691000},"page":"1649-1657","source":"Crossref","is-referenced-by-count":127,"title":["Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysis"],"prefix":"10.1093","volume":"58","author":[{"given":"Irene S.","family":"Kourbeti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis D.","family":"Ziakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"key\n\t\t\t\t20170522115510_CIU185C1","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1073\/pnas.95.24.14447","article-title":"Perturbation of the T cell repertoire in rheumatoid arthritis","volume":"95","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170522115510_CIU185C2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.rdc.2012.08.019","article-title":"Infections and biologic therapy in rheumatoid arthritis: our changing understanding of risk and prevention","volume":"38","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"key\n\t\t\t\t20170522115510_CIU185C3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2008.10.002","article-title":"The risk of infections with biologic therapies for rheumatoid arthritis","volume":"39","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522115510_CIU185C4","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522115510_CIU185C5","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170522115510_CIU185C6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1503\/cmaj.091391","article-title":"A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview","volume":"181","year":"2009","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t20170522115510_CIU185C7","doi-asserted-by":"crossref","first-page":"e30275","DOI":"10.1371\/journal.pone.0030275","article-title":"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170522115510_CIU185C8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/art.30310","article-title":"Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"63","year":"2011","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522115510_CIU185C9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2007.083188","article-title":"Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials","volume":"68","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522115510_CIU185C10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/ajg.2013.138","article-title":"Opportunistic infections with anti-tumor necrosis factor-alpha therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials","volume":"108","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20170522115510_CIU185C11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.berh.2011.10.012","article-title":"Established rheumatoid arthritis: rationale for best practice: physicians\u2019 perspective of how to realise tight control in clinical practice","volume":"25","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key\n\t\t\t\t20170522115510_CIU185C12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522115510_CIU185C13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines. 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20170522115510_CIU185C14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events","volume":"26","year":"2007","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170522115510_CIU185C15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","year":"2004","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170522115510_CIU185C16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6: rating the quality of evidence--imprecision","volume":"64","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20170522115510_CIU185C17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522115510_CIU185C18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/sim.4780080202","article-title":"A comparison of statistical methods for combining event rates from clinical trials","volume":"8","year":"1989","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170522115510_CIU185C19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","year":"1997","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522115510_CIU185C20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates","volume":"326","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170522115510_CIU185C21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.berh.2011.10.004","article-title":"Anti-TNF therapy","volume":"25","year":"2011","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"key\n\t\t\t\t20170522115510_CIU185C22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.NPR.0000421427.01505.0e","article-title":"Rheumatoid arthritis: new treatments, better outcomes","volume":"37","year":"2012","journal-title":"Nurse Pract"},{"key":"key\n\t\t\t\t20170522115510_CIU185C23","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.091025","article-title":"The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events","volume":"68","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522115510_CIU185C24","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/art.22808","article-title":"Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies","volume":"56","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522115510_CIU185C25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522115510_CIU185C26","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522115510_CIU185C27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522115510_CIU185C28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/keq368","article-title":"Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries","volume":"50","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522115510_CIU185C29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/art.23112","article-title":"The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom","volume":"57","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170522115510_CIU185C30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/annrheumdis-2011-201108","article-title":"Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"72","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170522115510_CIU185C31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents","volume":"301","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522115510_CIU185C32","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/rheumatology\/kes244","article-title":"Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis","volume":"51","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20170522115510_CIU185C33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","article-title":"Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry","volume":"69","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T14:16:06Z","timestamp":1597587366000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/ciu185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,18]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,3,18]]},"published-print":{"date-parts":[[2014,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciu185","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,18]]}}}